mayo clinic weight loss glp-1 GLP-1s and Aging: Risks, Benefits & After 60 | Aging Forward Podcast mayo clinic glp-1 program A

GIP receptor activation appears to amplify the metabolic benefits beyond what GLP-1 agonism alone can achieve, which is why tirzepatide consistently outperforms semaglutide in head-to-head comparisons

also all the research that shows that cessation of GLP 1 medication following weight loss invariably results in weight regain in the next 12 months

No increase in number of adverse events with increasing renal or hepatic impairment was observed, and no new safety or tolerability findings with cagrilintide were identified with renal or hepatic impairment

Vitamin B12 injections versus oral supplements

Individually sealed for integrity and freshness